Home > Insider Trading > Filing (0001209191-20-012017)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1668243	Urogen Pharma Ltd.	URGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585839	P. Peter Pfreundschuh	C/O Urogen Pharma Ltd. 400 Alexander Park Princeton NJ 08540	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2020-02-20	1,042	$0.00	6,480	No	4	M	Direct
Ordinary Shares	Disposition	2020-02-20	360	$29.68	6,120	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units	Disposition	2020-02-20	1,042	$0.00	1,042	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,249			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
This amount includes 1,000 shares reported on Reporting Person's Form 3 that were omitted from subsequent Form 4 filings.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter.